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Abstract
Colorectal cancer (CRC) holds the woeful record of being the most preventable but least prevented type of cancer. Although healthy 
lifestyles and screening programs associated to early polyp removal greatly reduce CRC incidence and CRC-related death, the overall 
lack of information and of effective preventive policies is promoting an overwhelming global escalation of this disease. Moreover, new 
challenges such as the increasing occurrence of aggressive CRC in young adults highlight underlying changes not only in the incidence 
but also in the nature of this disease. In this scenario, CRC prevention should also undergo a significant transformation, embracing not 
only individual initiatives but also issues of social and international relevance. The nascent network of countries surrounding the Mediter-
ranean basin (COLOMED, the COLOrectal cancer MEDiterranean network) serves as a paradigm of international cooperation aimed at 
broadening scientific collaboration and promoting effective health policies in CRC research and prevention.
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Introduction
The global CRC burden is expected to increase by 60% to more than 2.2 million new cases and 1.1 million deaths by 2030, correlating 
with human development levels and with the adoption of western lifestyles [1]. Generally, low-income and middle-income countries are 
experiencing a sharp increase in CRC incidence and mortality, whereas industrialized countries have very high CRC rates undergoing 
stabilization or slight decrease. Furthermore, an unprecedented increase of CRC cases in young adults is occurring in developed coun-
tries, often presenting at advanced stages and with aggressive features [2]. Among early onset CRC patients, 30% belong to families with 
genetic predisposition, who require dedicated screening and management programs [3]. In the Mediterranean area, despite shared biogeo-
graphical features and nutritional habits, EU and non-EU countries present vast disparities in CRC incidence, mortality and management, 
as recently highlighted by the EUROMED CANCER Network survey [3]. Specifically, non-EU Mediterranean countries reported a high 
incidence/mortality rate, poor awareness among the population, and a lack of both comprehensive screening programs and of qualified 
medical personnel [4]. In this context, COLOMED is committed to promote the collaboration between Mediterranean countries in the fight 
against CRC. International cooperation initiatives are increasingly needed to support national actions and advocate health policies aimed 
at supporting CRC prevention.
CRC prevention and screening across the Mediterranean: a synthetic overview
Since December 2003, when the Council Recommendation on CRC screening was issued, a number of countries have implemented orga-
nized screening programs. In the meantime, evidence on the efficacy and effectiveness of the fecal occult blood test (FOBT) among 50-74 
year olds has been reported. A Cochrane review of randomized controlled trials showed a 25% relative risk reduction in CRC mortality 
(RR 0.75, CI: 0.66 - 0.84) for those attending at least one round of screening using FOBT, when adjusted for screening attendance in the 
individual studies [5]. Further data on effectiveness confirmed these results (27% reduction in CRC mortality in a routine screening program 
when restricted to participants). The European Partnership for Action Against Cancer (EPAAC) and the later Cancer Control Joint Actions 
(CanCon JA) called, however, for a further integration of the National Cancer Plans across EU Member States by 2020, and for the setting 
up of a National Structures for the governance of screening in each Member State [6]. According to a recent report of the EU Commission, 
the current status of CRC screening in Europe sees 23 countries with a population based program either already implemented or in the 
planning phase, of which 11 countries have rollout completed either nationwide or regionally [7]. Though a majority of the screening is still 
by FOBT, large proportions of the target population have access to screening by endoscopy (flexible sigmoidoscopy or total colonoscopy). 
To secure the benefits of screening, however, routine linkage between screening registries and the registries containing relevant data 
(morbidity and mortality for cancer) for defining the population, performance and outcome is essential and can be considered an ethical 
requirement of screening, as underlined in a relevant section of the European Guide on Quality Improvement in Comprehensive Cancer 
Control from CanCon JA [6]. Concerning Mediterranean countries outside of the EU, the WHO Country profile of 2014 [8] reports that most 
of them have national cancer plans, although CRC screening programs are not implemented elsewhere (e.g. Egypt, Morocco).
Relevance of intersectoral and international initiatives in CRC prevention
It is widely accepted that CRC is closely linked to lifestyle-related factors such as nutrition, smoking, alcohol consumption and physical activ-
ity. However, such factors are not only dictated by individual choices but are closely interconnected to social health determinants such as 
inequalities, environment, education, employment, food, housing, water, transport and energy [9]. All these sectors will need to be addressed 
by appropriate actions in order to implement effective policies of CRC prevention, which will be as important as primary and secondary pre-
ventive strategies. In parallel, according to the WHO assessment that “the health of all peoples is dependent upon the fullest co-operation of 
individuals and States” [10], regional and global collaboration is also required to complement individual and national actions against CRC. In 
line with this view, in 2017 COLOMED organized an advanced theory-practice course on CRC stem cells for young scientists coming from 
non-EU Mediterranean countries and an international meeting where representatives from several Mediterranean countries, associations 
and institutions exchanged views and strategies about CRC prevention and treatment. In the future, continuous cooperation between Medi-
terranean countries will be crucial to support national initiatives and to promote medical and scientific collaboration.
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Conclusion
While developing countries struggle with a dramatic increase in CRC, industrialized countries deal with stable high incidence rates and 
changing epidemiological patterns among the population. National and international initiatives are required to successfully face this dynamic 
scenario and implement effective prevention strategies against CRC.
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